TWD
KNSA icon

True Wealth Design’s Kiniksa Pharmaceuticals KNSA Stock Holding History

True Wealth Design’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.9K Hold
687
– – 0.01% 541
2026
Q1 		$33.1K Hold
687
– – 0.01% 530
2025
Q4 		$28.3K Hold
687
– – 0.01% 499
2025
Q3 		$26.7K Hold
687
– – 0.01% 501
2025
Q2 		$19K Buy
687
+158
+30% +$4.02K 0.01% 394
2025
Q1 		$11.8K Buy
529
+317
+150% +$6.53K ﹤0.01% 432
2024
Q4 		$4.19K Buy
212
+46
+28% +$1.05K ﹤0.01% 564
2024
Q3 		$4.15K Buy
+166
New +$4.04K ﹤0.01% 608

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

True Wealth Design's KNSA Position: Q2 2026 in Review

True Wealth Design held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 687 shares worth $43.9K. The position accounts for 0.01% of the portfolio, ranked #541.

True Wealth Design first reported a position in KNSA in Q3 2024 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • True Wealth Design held 687 shares of Kiniksa Pharmaceuticals worth $43.9K as of Q2 2026.
  • True Wealth Design left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #541 holding.
  • True Wealth Design first reported a position in Kiniksa Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.